TOS / OMA / OAC Expert Guidance Statement on Obesity Pharmacotherapy: A Humbling Call to Action
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Beverly G. Tchang, Donna H. Ryan |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Joint TOS / OMA / OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach
by: Lydia Alexander, et al.
Published: (2026)
by: Lydia Alexander, et al.
Published: (2026)
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
by: Hamlet Gasoyan, et al.
Published: (2025)
by: Hamlet Gasoyan, et al.
Published: (2025)
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid‐lowering treatment in five randomized controlled STEP trials
by: Beverly G. Tchang, et al.
Published: (2025)
by: Beverly G. Tchang, et al.
Published: (2025)
Correction to “Defining and Diagnosing Obesity in India: A Call for Advocacy and Action”
Published: (2025)
Published: (2025)
Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy
by: Alexander D. Miras, et al.
Published: (2026)
by: Alexander D. Miras, et al.
Published: (2026)
Body weight reduction in women treated with tirzepatide by reproductive stage: a post hoc analysis from the SURMOUNT program
by: Beverly G. Tchang, et al.
Published: (2025)
by: Beverly G. Tchang, et al.
Published: (2025)
The Role of Physical Activity in the Prevention and Management of Obesity: A Position Statement From the World Obesity Federation
by: Zoe Gowers, et al.
Published: (2026)
by: Zoe Gowers, et al.
Published: (2026)
Pharmacotherapies for Binge Eating Disorder: Systematic Review and Network Meta‐Analysis
by: Gabriel P. A. Costa, et al.
Published: (2025)
by: Gabriel P. A. Costa, et al.
Published: (2025)
Early‐Onset Obesity and Tirzepatide Treatment: A Post Hoc Analysis of the SURMOUNT Clinical Trials
by: Evgenia Gourgari, et al.
Published: (2025)
by: Evgenia Gourgari, et al.
Published: (2025)
A Narrative Review of Weight Management Strategies: From Lifestyle Interventions to Emerging Pharmacotherapies
by: Iman Saad Ahmed, et al.
Published: (2026)
by: Iman Saad Ahmed, et al.
Published: (2026)
Mitochondrial Transfer: A Novel Mechanism in the Development of Obesity and Obesity‐Related Metabolic Diseases
by: Lei Zhu, et al.
Published: (2026)
by: Lei Zhu, et al.
Published: (2026)
Father‐Focused Childhood Obesity Prevention Interventions: A Scoping Review
by: Sarah Latkolik, et al.
Published: (2025)
by: Sarah Latkolik, et al.
Published: (2025)
ObesityWeek ® 2025—Reflecting on an Exciting Time in Obesity Research and Treatment
by: Susan Z. Yanovski, et al.
Published: (2026)
by: Susan Z. Yanovski, et al.
Published: (2026)
Do Obesity Classifications Create the Obesity Paradox? A Scoping Review of Obesity Definitions Applied in Sepsis Research
by: Efris Kartikasari, et al.
Published: (2025)
by: Efris Kartikasari, et al.
Published: (2025)
Weight Loss, Obesity Medication, and Risk of Obesity‐Associated Cancer: A Meta‐Analysis of Randomized Controlled Trials
by: Chengwen Li, et al.
Published: (2025)
by: Chengwen Li, et al.
Published: (2025)
Response to: “Nutritional Priorities to Support GLP ‐1 Therapy for Obesity: A Joint Advisory From the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society”
Published: (2025)
Published: (2025)
National and International Clinical Guidelines for the Management of Obesity in Adults: A Systematic Review
by: Paul Doody, et al.
Published: (2026)
by: Paul Doody, et al.
Published: (2026)
Classification of Obesity Based on Weight History: Perceptions of People With Obesity
by: Bruno Halpern, et al.
Published: (2026)
by: Bruno Halpern, et al.
Published: (2026)
The Obesity Society 2024 Awards and Grants
Published: (2024)
Published: (2024)
Beyond BMI : The Impact of the New Lancet Commission Diagnostic Criteria on Prevalence of Obesity in the United States
by: Jennifer H. Hwang, et al.
Published: (2026)
by: Jennifer H. Hwang, et al.
Published: (2026)
Disseminating and Implementing the Science of Pediatric Obesity Treatment and Prevention
by: Amanda E. Staiano, et al.
Published: (2026)
by: Amanda E. Staiano, et al.
Published: (2026)
Priority Populations in Early Childhood Obesity Prevention Interventions: A Scoping Review
by: Talia Palacios, et al.
Published: (2025)
by: Talia Palacios, et al.
Published: (2025)
Sex Disparities in Obesity: A Comprehensive Review of Hormonal and Genetic Influences on Obesity‐Related Phenotypes
by: Yu‐Gyeong Lee, et al.
Published: (2025)
by: Yu‐Gyeong Lee, et al.
Published: (2025)
Measuring and Managing Obesity in Pregnancy Using the Edmonton Obesity Staging System: A Scoping Review
by: Taniya S. Nagpal, et al.
Published: (2025)
by: Taniya S. Nagpal, et al.
Published: (2025)
The Weight of Social Risk and Opportunities for Obesity Prevention
by: Stephanie P. Gilley, et al.
Published: (2026)
by: Stephanie P. Gilley, et al.
Published: (2026)
Obesity is associated with progressive brain structural changes
by: Huiling Zhou, et al.
Published: (2025)
by: Huiling Zhou, et al.
Published: (2025)
Systematic Review of Loneliness and Social Isolation Interventions in Obesity and Obesity‐Related Complications
by: Ghada Alsultany, et al.
Published: (2026)
by: Ghada Alsultany, et al.
Published: (2026)
Obesity Prevalence Among U.S. Adults With and Without Disabilities
by: Cheryl D. Fryar, et al.
Published: (2026)
by: Cheryl D. Fryar, et al.
Published: (2026)
Stopping Spin at the Source: Learning From an Example in Obesity
by: Andrew W. Brown, et al.
Published: (2026)
by: Andrew W. Brown, et al.
Published: (2026)
Family Considerations in the Treatment of Adult Obesity With Antiobesity Medications
by: Keeley J. Pratt, et al.
Published: (2025)
by: Keeley J. Pratt, et al.
Published: (2025)
Estradiol, Testosterone, and Central Obesity in the Biology of Male Aging
by: Sheng Li, et al.
Published: (2025)
by: Sheng Li, et al.
Published: (2025)
Clarification of our response to “The importance of diversity in Obesity articles”
by: Michelle Cardel, et al.
Published: (2024)
by: Michelle Cardel, et al.
Published: (2024)
Prevalence of Clinical Obesity in US Adults, 2017–2020
by: Yun Shen, et al.
Published: (2025)
by: Yun Shen, et al.
Published: (2025)
New Frontiers in Stand‐Alone Digital Obesity Treatment
by: Delia S. West, et al.
Published: (2025)
by: Delia S. West, et al.
Published: (2025)
Associations of Metal Mixtures During Early Pregnancy With Midlife Obesity and Body Composition: A Prospective Study
by: Mingyu Zhang, et al.
Published: (2025)
by: Mingyu Zhang, et al.
Published: (2025)
Perfectionism in Overweight and Obesity: A Scoping Review
by: Chantal P. Delaquis, et al.
Published: (2026)
by: Chantal P. Delaquis, et al.
Published: (2026)
Role of Acid‐Sensing Ion Channels 1a in the Regulation of Obesity and the Gut Microbiota
by: Jane Shearer, et al.
Published: (2025)
by: Jane Shearer, et al.
Published: (2025)
Disparities in Adolescent and Young Adult Obesity Medication Dispensing: A Retrospective Linked EHR ‐Pharmacy Cohort, 2020–2025
by: Isa Granados, et al.
Published: (2026)
by: Isa Granados, et al.
Published: (2026)
Neighborhood Environments and Changes in Obesity and in Lifestyle Behaviors Among Children Enrolled in Obesity Management Interventions: A Systematic Review
by: Yujia Tang, et al.
Published: (2025)
by: Yujia Tang, et al.
Published: (2025)
Placental Gene Expression Associated With Early Childhood Growth Trajectories and Obesity Risk
by: Hyo Young Choi, et al.
Published: (2025)
by: Hyo Young Choi, et al.
Published: (2025)
Similar Items
-
Joint TOS / OMA / OAC Expert Guidance Statement on the Pharmacological Management of United States Adults With Overweight or Obesity Using the GRADE Approach
by: Lydia Alexander, et al.
Published: (2026) -
Reasons for Discontinuation of Obesity Pharmacotherapy With Semaglutide or Tirzepatide in Clinical Practice
by: Hamlet Gasoyan, et al.
Published: (2025) -
Effect of semaglutide 2.4 mg on use of antihypertensive and lipid‐lowering treatment in five randomized controlled STEP trials
by: Beverly G. Tchang, et al.
Published: (2025) -
Correction to “Defining and Diagnosing Obesity in India: A Call for Advocacy and Action”
Published: (2025) -
Targeting Multiple Gut‐Brain Pathways in Obesity: Rationale for Combination Pharmacotherapy
by: Alexander D. Miras, et al.
Published: (2026)